PUBLIC COMPANY
save$APTOFAptose Biosciences Inc.
$APTOFToronto, Ontario, Canadaupdated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- phase1A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
- phase1A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that